Nocturia & Lower Urinary Tract Conditions VL

GEMTESA® (vibegron) for the Treatment of Patients with Overactive Bladder FDA Approved - Scott A. MacDiarmid

Details
Joining Diane Newman on UroToday's Bladder Health Center of Excellence is Scott MacDiarmid to discuss the United States Federal Drug Administration (FDA) approval of beta-3 agonist, GEMTESA® (vibegron), for the treatment of overactive bladder (OAB). This approval marks the first new oral branded OAB medication approved by the FDA since 2012. Biographies: Scott A. MacDiarmid, MD is director of the...

Advancements in Pharmacological and Device-Based OAB Treatment Options - Eric Rovner

Details
There are multiple treatments for overactive bladder (OAB): behavioral therapies, pharmacological therapies, and office-based therapies such as percutaneous tibial nerve stimulation, a variety of surgeries, and sacral neuromodulation are currently being used. Joining Thomas Keane, MBBCh, FRCSI, FACS, to discuss the various advancements, both present and upcoming, in the field of overactive bladder...

Management of Nocturia- Mikel Gray

Details
Mikel Gray focusses on the management of nocturia, highlighting treating comorbid conditions that lead to nocturia, treating overactive bladder and lower urinary tract symptoms, pharmacotherapy treatments, and behavioral interventions. Biographies: Mikel Gray, Ph.D., PNP, FNP, CUNP CCCN, FAANP, FAAN, Professor and Nurse Practitioner of Urology and School of Nursing, Certified Urologic Nurse Practi...

The Impact of Sleep Disruptions Caused by Nocturia - Experts Roundtable

Details
Benjamin Brucker assembles voiding dysfunction experts focused on the clinical implications of lower urinary tract symptoms. The conversation shines the light on how these experts think about the symptoms considered in the diagnosis between overactive bladder and nocturia. Patients experiencing nighttime awakenings to void is disruptive not only to their sleep but to day time functioning. How do w...

Nocturia: Physiology and Pathophysiology - Mikel Gray

Details
Mikel Gray presents, “Nocturia: Advanced Concepts for the Urologic and Urogynecologic Specialist” focusing on the physiology and pathophysiology of nocturia. Mikel reviews the influence of age and gender on nighttime urine production and the prevalent sleep disorders associated with nocturia. Biographies: Mikel Gray, Ph.D., PNP, FNP, CUNP CCCN, FAANP, FAAN, Professor and Nurse Practitioner of Urol...

A Contemporary Assessment of Nocturia - Mikel Gray

Details
Mikel Gray presents the key elements to examine in the assessment of nocturia including sleep patterns, history of lower urinary tract symptoms, medication review, and any comorbid conditions. Mikel also describes the importance of a bladder log or voiding diary and other instruments that characterize storage/voiding/ post void LUTS in the assessment of nocturia. Biographies: Mikel Gray, Ph.D., PN...

Urologic Complications of Neurologic Disease, Focus on the Patient with Multiple Sclerosis - Lysanne Campeau

Details
A conversation with Lysanne Campeau and Ben Brucker on treatment options for Multiple Sclerosis patients who present with neurologic disease. In this at-risk population, clinicians must consider comorbities, polypharmacy and the level of disability for each patient. The role of counseling appropriately to include the patient in the treatment decision plan is a routine practice for these providers....

Nocturia... It's Not Overactive Bladder - Scott MacDiarmid

Details
(Length of Discussion: 20 min) Scott MacDiarmid presents on nocturia, the assessment, diagnosis, management and rationale for therapeutic treatment options. Nocturia is highly prevalent, and significantly impacts quality of life, so defining an algorithm for treatment is critical for the success in diagnosing early and treating effectively. Biography: Scott A. MacDiarmid, MD is director of the All...

Minimally Invasive Approaches in the Treatment of BPH: Ready to Replace TURP? - Claus Roehrborn

Details
Claus Roehrborn provides a state of the art review on contemporary management of male lower urinary tract symptoms and BPH. Biography: Claus Roehrborn, MD is at the Harold C. Simmons Comprehensive Cancer Center. Dr. Roehrborn is the S.T. Harris Family Chair in Medical Science, in Honor of John D. McConnell, M.D. and the E.E. Fogelson and Greer Garson Fogelson Distinguished Chair in Urology. A worl...

Defining Nocturia and Management Strategies - Alan Wein

Details
(Length of Discussion: 29 minutes) Alan Wein provides a presentation from the Société Internationale d'Urologie (SIU) 2018 meeting on nocturia. He defines nocturia highlighting the clinical implications to patients, related to frequency and bother. He reviews therapies and discusses management of these patients for practitioners to consider. Biography: Alan J. Wein, MD, Ph.D. (Hon). FACS, Surgeon,...